Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Cábez

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Gastroenterologia Y Hepatologia|December 22, 2025
Etrasimod: review of the safety and practical management considerations of a new oral therapy for the treatment of ulcerative colitisYamile Zabana, Ana Cábez, Ana Gutiérrez Casbas
World Journal of Gastroenterology|February 27, 2023
Medical consultation in ulcerative colitis: Key elements for improvementYago González-Lama, Elena Ricart, Ana Cábez, et al.
Arthritis Research & Therapy|April 17, 2020
Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter studyRuben Queiro, Juan D Cañete, María Montoro, et al.
Arthritis Research & Therapy|March 31, 2017
Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter studyRubén Queiro, Juan D Cañete, Carlos Montilla, et al.
The Journal of Rheumatology|February 3, 2019
Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic ArthritisRuben Queiro, Juan D Cañete, Carlos Montilla, et al.
Gastroenterologia Y Hepatologia|May 9, 2024
Use of digital health tools in inflammatory bowel diseaseIago Rodríguez-Lago, Beatriz Gros, Kristy Sánchez, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 22, 2021
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in SpainCarlos Taxonera, Fernando de Andrés-Nogales, Santiago García-López, et al.
Gastroenterologia Y Hepatologia|December 22, 2025
Management of refractory ulcerative proctitisManuel Barreiro-de Acosta, Francisco Mesonero, Rocío Ferreiro-Iglesias, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Gastroenterologia Y Hepatologia|December 22, 2025
Etrasimod: review of the safety and practical management considerations of a new oral therapy for the treatment of ulcerative colitisYamile Zabana, Ana Cábez, Ana Gutiérrez Casbas
World Journal of Gastroenterology|February 27, 2023
Medical consultation in ulcerative colitis: Key elements for improvementYago González-Lama, Elena Ricart, Ana Cábez, et al.
Arthritis Research & Therapy|April 17, 2020
Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter studyRuben Queiro, Juan D Cañete, María Montoro, et al.
Arthritis Research & Therapy|March 31, 2017
Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter studyRubén Queiro, Juan D Cañete, Carlos Montilla, et al.
The Journal of Rheumatology|February 3, 2019
Very Low Disease Activity, DAPSA Remission, and Impact of Disease in a Spanish Population with Psoriatic ArthritisRuben Queiro, Juan D Cañete, Carlos Montilla, et al.
Gastroenterologia Y Hepatologia|May 9, 2024
Use of digital health tools in inflammatory bowel diseaseIago Rodríguez-Lago, Beatriz Gros, Kristy Sánchez, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|February 22, 2021
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in SpainCarlos Taxonera, Fernando de Andrés-Nogales, Santiago García-López, et al.
Gastroenterologia Y Hepatologia|December 22, 2025
Management of refractory ulcerative proctitisManuel Barreiro-de Acosta, Francisco Mesonero, Rocío Ferreiro-Iglesias, et al.
Pageof 1